Table 3. Essential medicine list applications where price or economic evaluation are mentioned in final reports from the WHO Expert Committee on the Selection and Use of Essential Medicines, 2002–2013.
| Type | No. of applications (%) |
|||
|---|---|---|---|---|
| Complete information | Incomplete information | No informationa | Total | |
| Price | ||||
| Not mentioned | 14 (50) | 44 (56) | 20 (74) | 78 (58) |
| Mentioned | 14 (50) | 35 (44) | 7 (26) | 56 (42) |
| Total | 28 (100) | 79 (100) | 27 (100) | 134 (100) |
| Economic evaluation | ||||
| Not mentioned | 10 (40) | 4 (50) | 79 (78) | 93 (69) |
| Mentioned | 15 (60) | 4 (50) | 22 (22) | 41 (31) |
| Total | 25 (100) | 8 (100) | 101 (100) | 134 (100) |
WHO: World Health Organization.
a Applications where no information was provided for price and economic evaluation, plus those where the applicant explicitly noted that price and economic evaluation data did not exist for the medicine and those earlier classified as not applicable.